Cargando…
Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China
Macrolides such as erythromycin are the empirical treatment of Bordetella pertussis infections. China has experienced an increase in erythromycin-resistant B. pertussis isolates since they were first reported in 2013. Here, we undertook a genomic study on Chinese B. pertussis isolates from 2012 to 2...
Autores principales: | Xu, Zheng, Wang, Zengguo, Luan, Yang, Li, Yarong, Liu, Xiaoguai, Peng, Xiaokang, Octavia, Sophie, Payne, Michael, Lan, Ruiting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455148/ https://www.ncbi.nlm.nih.gov/pubmed/30898080 http://dx.doi.org/10.1080/22221751.2019.1587315 |
Ejemplares similares
-
Genomic epidemiology and multilevel genome typing of Bordetella pertussis
por: Payne, Michael, et al.
Publicado: (2023) -
The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study
por: Wang, Zengguo, et al.
Publicado: (2020) -
Genomic dissection of the microevolution of Australian epidemic Bordetella pertussis
por: Xu, Zheng, et al.
Publicado: (2022) -
Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine
por: Safarchi, Azadeh, et al.
Publicado: (2019) -
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017
por: Xu, Zheng, et al.
Publicado: (2019)